Autopsy report · NCT03414788
Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderate To Severe Ulcerative Colitis and Crohn's Disease
Cause of deathSlow enrollment
“The study was withdrawn due to not being able to recruit subjects.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 1
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Inflammatory Bowel Disease
- Interventions
- PF 06687234; [124I]IB PF 06687234
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- DELPhI Evaluation of Psychiatric Conditions
“Study was withdrawn due to recruitment difficulties” - Ozurdex Monotherapy Trial
“The study was withdrawn due to insufficient participant enrollment.” - The Role of Splinting in Fingertip Injuries
“Very few subjects were enrolled. Therefore, the study was terminated.” - Maxi-Analgesic Osteoarthritis (OA) Study
“The study was withdrawn for administrative reason” - BLOOM: Boldly Living outdOOrs for Mental Health
“Study was withdrawn because available funding ended and could not be extended. No participants were enrolled.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.